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Abstract 
Interstitial pregnancy is an ectopic pregnancy at high hemorrhagic risk. It often poses a diagnostic 
and therapeutic challenge to the clinician, with a significant risk of morbidity and mortality. It 
presents a difficult management problem with no absolute standard of care; the most appropriate 
treatment technique for these pregnancies remains controversial. We describe a case of unruptured 
interstitial pregnancy successfully treated with a single-dose of systemic methotrexate with 
subsequent ultrasound and serum beta human chorionic gonadotropin monitoring. Medical 
management can be a safe and successful option in selected cases that satisfy specific criteria and in 
women who are able to be monitored after treatment. 
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INTRODUCTION 
Interstitial pregnancy refers to an ectopic pregnancy (EP) that is implanted in the interstitial portion 
of the fallopian tube.[1,2] 
It represents almost 2-4% of all ectopic pregnancies, but its incidence is unclear and is increasing 
because of the large use of assisted reproductive techniques in recent years. Other risk factors 
include pelvic inflammatory disease, previous ipsilateral or bilateral salpingectomy, previous EP, 
previous tubal sterilization, uterine anomalies and a history of sexually transmitted infections.[1,3] 
Diagnosis can be delayed due to the difficulty of distinguishing an interstitial pregnancy from an 
intrauterine pregnancy (in particular an angular pregnancy) in the early ultrasound (US) 
scanning.[4,5] 
The mortality rate is as high as 2.5% (7 times higher than that of ectopic pregnancies in general). 
Thus, early detection and a high index of suspicion are crucial to reduce morbidity and mortality.[1] 
Interstitial pregnancies present a difficult management problem with no absolute standard of care; 
several treatments are proposed, both medical and surgical, but the most appropriate technique for 
the treatment of these pregnancies remains controversial.[1,5] 
In this report, we describe a case of unruptured interstitial pregnancy successfully treated with a 
single-dose of systemic methotrexate with subsequent US and serum beta human chorionic 
gonadotropin (b-hCG) monitoring. 
CASE REPORT 
A 36-year-old Chinese woman, gravida 2 para 1, was admitted in 2013 to our tertiary center 
(Careggi University Hospital, Florence, Italy) at 6 ± 4 weeks of amenorrhea for a suspicion of EP. 
She was affected by essential hypertension in therapy with nifedipine given orally at a dose of 30 
mg once daily. Her obstetric history included a normal vaginal delivery at 16 years old. At 17-year-
old she underwent a tubal ligation with clip method in China because she didn’t desire any other 
children in that period; 2 years before admission she decided to remove it. 
Her general conditions were stable, and she did not refer any abdominal-pelvic symptom. The 
abdominal and vaginal examination did not reveal the pain. A mild vaginal bleeding was noted. 
At the time of admission, serum level of hCG was 8681 IU/L and hemoglobin was 13.6 g/dL. 
Transvaginal US revealed an empty uterus with two anterior fibroids of <2 cm. In the left uterine 
horn, a mass of 37 mm × 34 mm with a hypoechoic central area was present without sign of the 
fetal pole. The color Doppler showed the presence of a vascular ring, which proved an intense 
peripheral vascularization. Adnexa appeared normal; a corpus luteum was present in the right 
ovary. No free fluid was noted in Douglas pouch [Figure 1]. 
All blood tests were analyzed in the same laboratory (Careggi University Hospital, Florence, Italy) 
and all the transvaginal US were performed by the same person. 
Considering the serum level of hCG (<10,000 IU/L), the patient's stable hemodynamic state, the 
size of the mass (diameter <4 cm), the absence of abdominal free fluid and the absence of hepatic, 
renal and hematological impairment, according with the patient we decided for conservative 
management and we performed medical therapy with methotrexate (a single-dose of intramuscular 
methotrexate 1 mg/kg, according to the protocol of our center, prepared by the centralized unit for 
cytotoxic drug preparations of Careggi University Hospital). She didn’t have any side effects after 
treatment. 
At follow-up US 6 days after treatment the mass reached a size of 46 mm × 37 mm and didn’t 
present a recognizable cleavage plane with the myometrium. 
The patient was hospitalized for 11 days after treatment and remained asymptomatic throughout the 
hospital stay. This prolonged hospitalization was linked to the suspicion of poor compliance of the 
patient and to the need for accurate monitoring during the 1st days after this kind of treatment. The 
serum level of hCG decreased to 1570 IU/L on the day of discharge. The US check at discharge 
revealed two necrosis areas inside the mass and a reduction of peripheral vascularization [Figure 2]. 
The hCG level became negative 2 months later [Table 1]. 
The patient continued to be followed at the US center with transvaginal US performed every 2 
weeks for the first 3 months and then monthly for further 3 months by the same operator that had 
performed US during hospitalization. She remained asymptomatic during the entire period of 
follow-up. At follow-up US 3 months after discharge the size of the mass in the left uterine horn 
was reduced to 32 mm × 27 mm with the persistence of a minimal vascularization. The US check 
performed 6 months after discharge showed an important reduction of the mass (19 mm × 16 mm) 
with the absence of vascularization [Figure 3]. We suggested the patient not to become pregnant for 
further 6 months after the period of follow-up. 
The patient came to our center for routine gynecological visit in view of a future pregnancy about 1-
year after treatment. The US check showed the complete resolution of the mass, so she could try to 
have a new pregnancy. 
DISCUSSION 
Interstitial pregnancy is an EP at high hemorrhagic risk, due to the rich vascular pattern of the 
interstitial portion of the fallopian tube supplied by ovarian and uterine arteries.[6] 
Even if its prevalence is uncertain, due to a difficult differential diagnosis with angular pregnancies, 
an interstitial pregnancy should be considered in case of presence of risk factors for this disease: In 
our case, the patient had a previous tubal sterilization that is a high risk condition. 
It's important to consider that trophoblastic tissue produces b-hCG almost 8 days after conception, 
with a normal doubling period of approximately 48 h, and an intrauterine sac should be viewed with 
US when b-hCG are equal ore more than 1000 IU/L. When an interstitial pregnancy is suspected, on 
the basis of clinical signs or the presence of risk factors, a US exam should be performed as soon as 
possible. Several US features allow an early diagnosis such as an eccentric gestational sac 
surrounded by asymmetric and thin (<5 mm) myometrial layer, an empty uterine cavity and a thin 
echogenic line (“interstitial line sign”) that originates from the endometrium and carries on the edge 
of the bulking interstitial mass.[7,8] 
In case of uncertain diagnosis three-dimensional US or magnetic resonance imaging can be 
performed but for our patient the diagnosis was clearly identified using transvaginal US; the US 
evaluation, performed by an expert staff, showed the typical features of interstitial pregnancies 
[Figure 1].[9] 
Differential diagnosis with an angular pregnancy is a critical aspect. While an interstitial pregnancy 
is implanted in the uterine portion of the tube, angular pregnancy is an intrauterine pregnancy 
located near the utero-tubal junction. 
These two ectopic pregnancies cause a different uterine distortion: Usually the angular pregnancy 
leads to a bulge medial to the round ligament, and the interstitial one determines a lateral bulge. 
Ultrasound differential diagnosis is based on the features of the myometrium adjacent to the 
gestational sac. Myometrium is thicker in angular pregnancies and surrounds all sides of the sac 
while in interstitial pregnancies it is present only in the supero-lateral portion of the sac. This 
feature was visible in our US exam [Figure 1]. 
The most common symptom of EP is vaginal bleeding associated with pain and lower abdominal 
cramps. Women with interstitial pregnancy could remain asymptomatic for several weeks because 
the interstitial portion of the tube can expand a lot before rupture, more than other tubal segments. 
In the present patient, however, vaginal bleeding was an early symptom since it appeared before 7 
weeks of amenorrhea, even if it was minimal at examination. 
Traditional treatment for interstitial pregnancy consisted of cornual wedge resection or 
hysterectomy via laparotomy. This kind of surgery was considerably invasive and associated with 
high morbidity and negative effects on future woman fertility.[4,5] 
More recently, less invasive laparoscopic techniques have developed. Laparoscopic cornual 
resection is well-described in literature, it is generally an effective and quite safe procedure if 
performed by an expert surgeon, but it could be complicated by important bleeding; additionally, 
surgery leaves a scar in an already weakened uterine wall and subsequently women are advised that 
future pregnancies should be delivered by elective caesarean section to avoid the risk of uterine 
rupture.[1,4,5] 
The development of high-resolution US evaluation and rapid quantitative b-hCG assays has allowed 
the early detection of interstitial pregnancy, before the rupture, which has made possible a 
conservative, noninvasive treatment, represented by medical treatment.[1,5,10] 
Medical management with methotrexate has been used as first-line treatment in appropriate cases. It 
has strict inclusion criteria (early gestation, diameter <4 cm, b-hCG <10,000 IU/L, no evidence of 
rupture) and success rates vary widely. This conservative treatment can be a successful option in 
cases that satisfy these criteria and in women who are able to be monitored for a quite long time 
after treatment and treated further if required.[5,10] 
In the present case, all treatment options were considered, both conservative treatments (expectant 
management, systemic methotrexate, local injection of methotrexate or potassium chloride, 
selective uterine artery embolization) and surgical treatments (laparoscopic cornual resection, mini-
cornual excision, cornuostomy, salpingotomy, transcervical suction evacuation, cornual wedge 
resection, hysterectomy).[1] The choice was depended on the gestational age at diagnosis, the 
clinical features and the patient's desire for future fertility. Since the diagnosis was early and made 
before rupture, a nonsurgical treatment option was chosen in order to avoid the uterine scar caused 
by surgical intervention and to give the patient the chance of a future vaginal delivery. In addition, 
the avoidance of anesthesia, necessary for a surgical strategy, would result in less morbidity for the 
patient. 
It was decided for systemic methotrexate, a folic acid antagonist that inactivates dihydrofolate 
reductase resulting in depletion of nucleic acid synthesis. 
The single-dose protocol was chosen, because it requires a shorter treatment with the use of a lower 
dose of the drug, and it results in fewer side effects while maintaining an efficacy equal to that of 
multiple-dose regimes. Our patient underwent an intramuscular single injection of methotrexate at a 
dose of 1 mg/Kg although several therapeutic regimes are described in the literature. 
Main side effects linked to methotrexate administration, such as tubal rupture or hemoperitoneum, 
were evaluated and an intensive follow-up was conducted for the early detection of pregnancy 
persistence and possible complications[11] with both serial measurements of serum hCG and 
transvaginal US performed by an expert operator. 
Human chorionic gonadotropin-value curves are used for monitoring patients treated conservatively 
and they are considered as an accurate marker for the identification of success or failure of the 
procedure.[12] 
Human chorionic gonadotropin levels after methotrexate show a high variability and a rapid 
increase in hCG values is not strictly predictive of unsuccessful treatment since it occurs in a certain 
percentage of cases undergoing the resolution.[12] 
As the French study of Bottin et al. showed, in our patient a 20% of decrease in hCG values 
between day 1 and day 4 after treatment seemed to be a predictive positive factor[13] [Table 1]. 
In conclusion, the early detection of interstitial EP with transvaginal US and sensitive serum b-hCG 
assays is the key for a successful management because it allows conservative methods instead of 
conventional surgical management, reducing the potential consequences on morbidity and 
subsequent fertility.[14] 
Our case report confirmed the evidences of other studies, showing that invasive treatment should 
not be the first-line management of interstitial pregnancy in hemodynamically stable patients and 
that single-dose of systemic methotrexate may be a safe, effective and successful option in women 
who satisfy specific criteria. 
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Figures and Tables 
Figure 1 
 
mass in the left uterine horn at patient admission with (a) and without (b) color Doppler 
Figure 2 
 
mass in the left uterine horn after treatment at patient discharge (in the context of the mass two 
areas of necrosis are visible) 
Table 1 
Human chorionic gonadotropin (hCG) values curve during 65 days after medical treatment (the 
serum level of hCG was analyzed in the same laboratory during hospitalization and during follow-




mass in the left uterine horn at follow-up visit 6 months after treatment with (a) and without (b) 
color Doppler 
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